Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial - Anker, SD; Butler, J; Filippatos, G (Circulation, 2021)
et al.